Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Sanofi
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Dana-Farber Cancer Institute
City of Hope Medical Center
Amgen
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Thomas Jefferson University
Children's Oncology Group
M.D. Anderson Cancer Center
Children's Oncology Group
Amgen
Children's Oncology Group
Fred Hutchinson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Medical College of Wisconsin
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
Children's Oncology Group
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
Therapeutic Advances in Childhood Leukemia Consortium